EUVIMEDEUVIMED entdecken
Open Access

Therapeutic plasma exchange-related complications in patients with immune-mediated thrombotic thrombocytopenic purpura.

Pasquale Agosti, Ilaria Mancini, Andrea Artoni, Chiara Cardone, Pasqualina De Leo, Christian Bichard, Addolorata Truma, Barbara Ferrari, Juri A Giannotta, Norma N Fantini, Maria Cristina Mocellin, Daniele Prati und 1 weitere

Blood transfusion · 08.05.2026 · 24 (3) · 251-259

DOI: 10.2450/bloodtransfus.1128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood transfusion, erschienen am 08.05.2026. Verfasst von Pasquale Agosti und 12 weiteren Autor:innen. Beteiligte Einrichtung: Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy. Hauptthemen laut MEDLINE: Plasma Exchange, Purpura, Thrombotic Thrombocytopenic, Purpura, Thrombocytopenic, Idiopathic. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Daily therapeutic plasma exchange (TPE) is the cornerstone of treatment for immune-mediated thrombotic thrombocytopenic purpura (iTTP). However, TPE is not a risk-free procedure and there is scarce evidence regarding its safety in iTTP. This study aims to describe the TPE-related clinical complications occurred in a cohort of patients hospitalized for an acute iTTP episode. MATERIALS AND METHODS: In this cross-sectional study, patients hospitalized for an acute iTTP episode at the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (Milan) between January 2016 and April 2022 undergoing a central venous catheter (CVC) placement to start TPE were enrolled. RESULTS: Thirty-three iTTP episodes from 32 patients were included, 20 (61%) first episodes and 2 (6%) complicated with acute exacerbations. Twenty-one episodes (64%) were complicated with at least one major TPE-related complication, 18 (55%) with at least one CVC-related complication, of which 9 (27%) with a major complication. Among major CVC-related complications, 5 were venous thromboses (VTs) requiring heparin treatment and CVC removal, and 3 infections (2 systemic) requiring systemic antibiotic treatment and CVC removal. The 19 CVC-related bleeds (in 16 episodes) were minor bleeds and required only local hemostatic medications. Among the major procedure-related complications, the most common were allergic reactions (present in 16 episodes, 49%), mostly urticarial rashes requiring systemic steroids and antihistamines, and clinical hypocalcemia (in 8 episodes, 24%). The episodes complicated with CVC-related VT or infection required a longer hospitalization and those complicated with CVC-related infection required also a higher number of TPE procedures. DISCUSSION: TPE procedure was well tolerated in our cohort of acute iTTP patients in the majority of cases, with CVC-related minor bleeds and allergic reactions being the most common complications. The occurrence of CVC-related major complications, as VT or infections, was associated with a longer hospitalization (medians: 30 vs 11.5 days).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasma ExchangePurpura, Thrombotic ThrombocytopenicPurpura, Thrombocytopenic, IdiopathicHumansMaleFemaleMiddle AgedAdultCross-Sectional StudiesAged

Autor:innen und Institutionen

  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy.
  • Università degli Studi di Milano, Department of Pathophysiology and Transplantation, Milan, Italy.
  • Department of Healthcare Professions, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Department of Transfusion Medicine and Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Zitieren

APA

Agosti, P., Mancini, I., Artoni, A., Cardone, C., De Leo, P., Bichard, C., Truma, A., Ferrari, B., Giannotta, J. A., Fantini, N. N., Mocellin, M. C., Prati, D., & Peyvandi, F. (2026). Therapeutic plasma exchange-related complications in patients with immune-mediated thrombotic thrombocytopenic purpura. Blood transfusion, 24(3), 251-259. https://doi.org/10.2450/bloodtransfus.1128

Vancouver

Agosti P, Mancini I, Artoni A, Cardone C, De Leo P, Bichard C, et al. Therapeutic plasma exchange-related complications in patients with immune-mediated thrombotic thrombocytopenic purpura. Blood transfusion. 2026;24(3):251-259. doi:10.2450/bloodtransfus.1128

BibTeX
@article{Agosti2026,
  author = {Agosti, Pasquale and Mancini, Ilaria and Artoni, Andrea and Cardone, Chiara and De Leo, Pasqualina and Bichard, Christian and Truma, Addolorata and Ferrari, Barbara and Giannotta, Juri A and Fantini, Norma N and Mocellin, Maria Cristina and Prati, Daniele and Peyvandi, Flora},
  title = {Therapeutic plasma exchange-related complications in patients with immune-mediated thrombotic thrombocytopenic purpura},
  journal = {Blood transfusion},
  year = {2026},
  volume = {24},
  number = {3},
  pages = {251--259},
  doi = {10.2450/bloodtransfus.1128}
}
Kostenlos starten →